Cargando…

Expression of Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor in Pancreatic Ductal Adenocarcinomas, Neuroendocrine Tumours and Chronic Pancreatitis

OBJECTIVE: Angiogenesis is a crucial event for pancreatic carcinogenesis, and it also plays an important role in chronic pancreatitis. The aim of our study was to evaluate the mRNA expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) in chronic inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelescu, Radu, Burada, Florin, Angelescu, Cristina, Gheonea, Dan Ionut, Iordache, Sevastița, Mixich, Francisc, Ioana, Mihai, Săftoiu, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062250/ https://www.ncbi.nlm.nih.gov/pubmed/24949370 http://dx.doi.org/10.4103/2303-9027.117692

Ejemplares similares

Power Doppler Endoscopic Ultrasound for the Assessment of Pancreatic Neuroendocrine Tumors
por: Iordache, Sevastiţa, et al.
Publicado: (2012)

The borderline resectable/locally advanced pancreatic ductal adenocarcinoma: EUS oriented
por: Iordache, Sevastiţa, et al.
Publicado: (2017)

Utility of Endoscopic Ultrasound Multimodal Examination with Fine Needle Aspiration for the Diagnosis of Pancreatic Insulinoma – A Case Report
por: Popescu, A., et al.
Publicado: (2012)

Epidermal Growth Factor Receptor in Pancreatic Cancer
por: Oliveira-Cunha, Melissa, et al.
Publicado: (2011)

Quantitative low mechanical index contrast-enhanced endoscopic ultrasound for the differential diagnosis of chronic pseudotumoral pancreatitis and pancreatic cancer
por: Gheonea, Dan Ionuţ, et al.
Publicado: (2013)

Mixed ductal-neuroendocrine carcinoma with unique intraductal growth in the main pancreatic duct
por: Hirata, Koji, et al.
Publicado: (2019)

Assessment of Ileal Crohn’s Disease Activity by Gastrointestinal Ultrasound and MR Enterography: A Pilot Study
por: Statie, Răzvan-Cristian, et al.
Publicado: (2023)

Endoscopic Ultrasound-Guided Fine Needle Aspiration: From the Past to the Future
por: Costache, Mădălin-Ionuț, et al.
Publicado: (2013)

Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy
por: Faller, Bryan A, et al.
Publicado: (2009)

Hepatocyte Growth Factor Signaling in Intrapancreatic Ductal Cells Drives Pancreatic Morphogenesis
por: Anderson, Ryan M., et al.
Publicado: (2013)

Gastric Cancer Angiogenesis Assessment by Dynamic Contrast Harmonic Imaging Endoscopic Ultrasound (CHI-EUS) and Immunohistochemical Analysis—A Feasibility Study
por: Sacerdoțianu, Victor Mihai, et al.
Publicado: (2022)

Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
por: Gao, He-Li, et al.
Publicado: (2020)

Pancreatic Collision Tumor of Ductal Adenocarcinoma and Neuroendocrine Tumor
por: Wang, Yuchen, et al.
Publicado: (2018)

Epidermal growth factor receptor expression in pancreatic lesions induced in the rat by azaserine.
por: Visser, C. J., et al.
Publicado: (1996)

The Differential Diagnosis of Chronic Pancreatitis
por: Gheonea, D.I., et al.
Publicado: (2009)

Cutaneous Toxicity in Oncologic Patients Receiving Epidermal Growth Factor Receptor Inhibitors
por: POPA, CRISTINA-MARIA, et al.
Publicado: (2021)

The Contribution of the Video Capsule Endoscopy in Establishing the Indication of Surgical Treatment in the Tumoral Pathology of the Small Bowel
por: Vere, C.C., et al.
Publicado: (2012)

The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer
por: Guo, Meng, et al.
Publicado: (2016)

Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles
por: Grapa, Cristiana Maria, et al.
Publicado: (2019)

Local Delivery of Gemcitabine Inhibits Pancreatic and Cholangiocarcinoma Tumor Growth by Promoting Epidermal Growth Factor Receptor Degradation
por: Jang, Sung Ill, et al.
Publicado: (2020)

Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma
por: Subramani, Ramadevi, et al.
Publicado: (2014)

Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study
por: Skubisz, Karolina, et al.
Publicado: (2023)

Predicting mortality in patients with nonvariceal upper gastrointestinal bleeding using machine-learning
por: Ungureanu, Bogdan Silviu, et al.
Publicado: (2023)

Heparin-Binding Epidermal Growth Factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia
por: Ray, Kevin C., et al.
Publicado: (2013)

Suppressive Effects of Vascular Endothelial Growth Factor-B on Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis
por: Albrecht, Imke, et al.
Publicado: (2010)

Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2022)

Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors
por: Ushio, Jun, et al.
Publicado: (2021)

Neuroendocrine Differentiation in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
por: Chang, Youjin, et al.
Publicado: (2013)

The Use of Endoscopic Ultrasonography in Inflammatory Bowel Disease: A Review of the Literature
por: Statie, Răzvan-Cristian, et al.
Publicado: (2023)

MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance
por: Farrell, Amy S., et al.
Publicado: (2017)

DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance
por: Danilov, Alexey V., et al.
Publicado: (2011)

Technique of qualitative and semiquantitative EUS elastography in pancreatic examination
por: Costache, Mădălin Ionuţ, et al.
Publicado: (2017)

Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell Carcinoma
por: An, Jeongshin, et al.
Publicado: (2019)

The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis
por: Guo, Chuangen, et al.
Publicado: (2018)

Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography
por: Ren, Shuai, et al.
Publicado: (2019)

MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas
por: Luan, Zhou, et al.
Publicado: (2021)

MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma
por: Fan, Yue, et al.
Publicado: (2016)

Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma
por: Zhao, J., et al.
Publicado: (2016)

Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor.
por: Mellon, J. K., et al.
Publicado: (1996)

Expression and localization of epidermal growth factor, transforming growth factor-α and epidermal growth factor receptor in the canine testis
por: TAMADA, Hiromichi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c4se8t3um1uf3lm8cqrkq50vgj